Last reviewed · How we verify
Norepinephrine 10 mcg
At a glance
| Generic name | Norepinephrine 10 mcg |
|---|---|
| Also known as | Levophed |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Angiotensin II in Liver Transplantation (PHASE2, PHASE3)
- Hand Perfusion and Pulse Oximetry Performance
- Early Versus Late Adjunctive Vasopressin in Septic Shock (PHASE4)
- Comparison of Plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) Level in De-resuscitation With Furosemide Group and Control Group (NA)
- Use of Vasopressors in Hypotension Associated With Spinal Anaesthesia in Caesarean Sections (NA)
- Norepinephrine With Ephedrine Versus Norepinephrine Alone During Spinal Anesthesia for Cesarean Delivery (PHASE4)
- Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients Undergoing Major Abdominal Procedures - A Pilot Study (NA)
- Hemodynamics During Cesarean Delivery Under Spinal Anesthesia With Norepinephrine Versus Ephedrine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Norepinephrine 10 mcg CI brief — competitive landscape report
- Norepinephrine 10 mcg updates RSS · CI watch RSS
- Cairo University portfolio CI